Psychedelic drug use linked to lower risk of psychological distress; Team tests a nanobody against norovirus;

> Building on a body of research that suggests certain party drugs can be used to effectively treat depression and other conditions, a new study by Johns Hopkins and the University of Alabama finds that a history of psychedelic drug use is linked to a lower risk of psychological distress, including a lower risk of suicidal thoughts. Release

> A team under Dr. Grant Hansman, a virologist who leads the CHS Research Group on Noroviruses at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University, has discovered that a "nanobody" called Nano-85 was able to bind to intact norovirus-like particles in culture. Release

Suggested Articles

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.

Arming a peptide taken from the virus that causes foot-and-mouth disease in cows with the payload tesirine shows promise against pancreatic cancer.